Delivery Order SPE2DB22D2006-SPE2DB25FW3XT
- Not listed
- The Defense Logistics Agency awarded a $2,570.68 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Rifampin 300 mg capsules (60 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $24.7K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily for treating tuberculosis and certain other...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis...
- The Defense Logistics Agency awarded a $17,169.04 delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count) on July 17, 2025, with a completion date of July 18, 2025. This is a firm fixed-price contract with no set-aside designation, awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,794.96 for Rifampin 300 mg capsules (60-count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract represents a non-competitive set-aside and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. Rifampin is an antibiotic commonly used in the treatment of tuberculosis and other mycobacterial infections, making this procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,020.97. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion on September 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $26,318.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) with an ultimate completion date of September 12, 2025. This competitively awarded, non-set-aside contract was issued on September 11, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used in the treatment of tuberculosis and other...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.80 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count packaging) on August 20, 2025, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count) with a ceiling value of $26,452.39. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 20, 2025, with AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serving as the place of performance. Rifampin is a critical antibiotic used in the treatment of tuberculosis and other mycobacterial infections, representing essential...
- The Defense Logistics Agency awarded a delivery order valued at $5,984.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is a child contract issued...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3XTDelivery Order
The Defense Logistics Agency awarded a $1,264.00 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a first-line antibiotic commonly used in the treatment of tuberculosis and other mycobacterial infections, making this a critical pharmaceutical supply for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The company's substantial contract portfolio with DLA demonstrates its established capability as a major pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/29/25 |